lascondes_28_03

132 / 154

458
hospitales generales, 4ta edición en español, Madrid, Harcourt
Brace de España,1998:37-71
3. Levenson J (ed), Textbook of Psychosomatic Medicine: Psychiatric
care and medically III (ed 2), Arlington, VA, American Psychiatric
Publishing, 2011.
4. Levenson J, Mc Donald M. The role of psychological factors in
cancer onset and progression: a critical appraisal, in the The
psycchoinmunology of Cancer, 2nd Edition, Edited by Lewis
CE, O’Brien R, Barraclough J. New York, Oxford University Press,
2002: 149-163.
5. Stoudemire A (ed). Psychological Factors Affecting Medical
conditions. Washington, DC, American Psychiatric Press,1995.
6. Levenson J. Factores psicológicos que afectan a las enfermedades
clínicas, Hales R, Yudofsky S, Gabbard G, Tratado de Psiquiatría
Clínica, 5ª Edición, Barcelona, Elsevier Masson España, 2009:
935-957.
7. Sanz J, Modolell E. Oncología y Psicología: un modelo de
interacción. Psicooncología. 2004;1: 3-12.
8. Holland JC, Lewis S, What is the human side of cancer?, Holland
JC, Lewis S, The human side of cancer, New York, Herder,2001:
1-49.
9. Holland JC. Psycho-Oncology: Overiew, obstacles and
opportunities. Psychooncology. 1992;1:1-13.
10. Lowitz B, Casciato D. Principios, definiciones y datos
estadísticos., Casciato D, Territo M, Manual de Oncología
Clínica, 6ª edición, Barcelona, Wolters Kluwer Health España,
2009: 3-19.
11. López E, Luque J. Filosofía de los cuidados paliativos, Couceiro
A, Ética en cuidados paliativos, 1ª edición, Madrid, Triacastella,
2004: 19-30.
12. Luco L. Cuidados paliativos: una deuda con los pacientes
terminales, Beca J, Astete C, Bioética clínica, Santiago de Chile,
Mediterráneo, 2012: 448-457.
13. Sánchez M. Enfermos terminales. Cuidados paliativos.
Adelantamiento de la muerte, Bioética en ciencias de la salud,
Barcelona, Elsevier Masson, 2013: 345-358.
14. Kübler-Ross E. Sobre la muerte y los moribundos, 6ta edición,
Barcelona, Grupo Editorial Ramdon House Mondadori, 1972.
15. Ley 20.584, Que regula Los derechos y deberes que tienen las
personas en relación con acciones vinculadas a su atención
en salud. Promulgada el 13 de abril de 2012. Documento
Generado en Noviembre 19, 2012, en
. Biblioteca del Congreso Nacional.
16. Sulmasy D, Hughes M, Thompson R, et al. How would terminally
ill patients have others make decisions for Them in the event of
decisional incapacity? A longitudinal study. J Am Geriatr Soc.,
2007;55,12:1981-1988.
17. Simón-Lorda P, La capacidad de los pacientes para tomar
decisiones: una tarea todavía pendiente, Rev. Asoc. Esp.
Neuropsiq., 2008; 28 (102): 325-350.
18. Rojas O. Estudio exploratorio acerca de los métodos empleados
por los oncólogos en la evaluación de la capacidad para la
toma de decisiones en salud de los pacientes oncológicos de
la región metropolitana, Tesis de Grado Magíster en Bioética,
Universidad de Chile, 2016, www.cybertesis.clhttp://www.
cybertesis
19. Philbrick K, Rundell J, Netzel P, J,Levenson J, Medicolegal
issues, Clinical Manual of Psychosomatic Medicine: A guide to
Consultation-Liaison Psychiatry, Second Edition, Washington
D.C., American Psychiatric Publishing,Inc, 2012:13-29.
20. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression,
anxiety,andadjustmentdisorderinoncological,haematological,
and palliative-care settings: a meta-analysis of 94 interview
based studies. Lancet Oncol. 2011; 12: 160-174.
21. Li M, Boquiren V, Lo C, et al. Depression and anxiety in supportive
oncology, Davis M, Feyer P, Ortner P,et al eds, Supportive
oncology, Philadelphia,PA, Elsevier, 2011:528-540.
22. Li M, Fitzgerald P, Rodin G. Evidence-based treatment of
depression with cancer. J Clin Oncol.2012; 30, 11: 1187-
1196.
23. Raison Ch, Miller AH. Depression in Cancer: New Developments
Regarding Diagnosis and Treatment. BIOL 2003;54:283–294
24. Ramasubbu R, Patten SB. Effect of depression on stroke
morbidity and mortality. Can J Psychiatry 2003; 48:250–7.
PMID: 12776392.
25. Stommel M, Given BA, Given CW: Depression and functional
status as predictors of death among cancer patients. Cancer.
2002. 94:2719–2727.
26. Faller H, Bulzebruck H, Drings P, Lang H.: Coping, distress, and
survival among patients with lung cancer. Arch Gen Psychiatry.
1999. 56:756–76.2
27. Koenig HG, Cohen HJ, Blazer DG, Meador KG, Westlund R, A brief
depression scale for use in the medically ill. Int J Psychiatry
Med. 1992. 22:183–195.
28. Koenig HG, Shelp F, Goli V, Cohen HJ, Blazer DG: Survival and
health care utilization in elderly medical inpatients with major
depression. J Am Geriatr Soc. 1989. 37:599–606.
29. Pelletier G, Verhoef MJ, Khatri N, Hagan N: Quality of life in brain
tumor atients: The relative contributions of depression, fatigue,
emotional distress, and existential issues. J Neurooncology,
2002. 57:41–49.
30. Stoudemire A, Thompson TL 2nd: Medication noncompliance:
Systematic approaches to evaluation and intervention. Gen
Hosp Psychiatry. 1983. 5:233–239.
31. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna
S, Goodkin RS, et al.: Paroxetine for the prevention of depression
induced by high-dose interferon alfa [see comments]. N Engl J
Med 2001a 344:961–966.).
32. Linden W, Vodermaier A, MacKenzie R, Greig D. Anxiety and
depression after cancer diagnosis: prevalence rates by cancer
type, gender, and age. J Affect Disord 2012;141(2–3):343–351
33. Mehnert A, Brähler E, Faller H et al. Four week prevalence of
mental disorders in patients with cancer across major tumour
entities. J Clin Oncol 2014;32:3540–355.
34. Yang YL, Liu L,Wang Y et al. The prevalence of depression and
anxiety among Chinese adults with cancer: a systematic review
and meta-analysis. BMC Cancer 2013;13:393.
35. Ciaramella A, Poli P: Assessment of depression among
[REV. MED. CLIN. CONDES - 2017; 28(3) 450-459]